Search results for Margetuximab
Margetuximab, Abbexa, abx831290
Margetuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB2/EGFR2/CD340, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Margetuximab is under investigation in clinical trial NCT03133988 (Margetuximab Expanded Access Program).
Host
Human, Mouse
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Margetuximab Biosimilar - Research Grade, ichor.bio, ICH5057
Detects human HER2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Margetuximab.
Host
CHO cells
Reactivity
Human
Applications
Conjugation
Research Grade Margetuximab (HY286046), abinScience, HY286046
Host
Chimeric
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.